Overview

INCB047986 in Rheumatoid Arthritis

Status:
Terminated

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to explore the safety, tolerability and efficacy of INCB047986, in subjects with moderate to severe rheumatoid arthritis.

Phase:

Phase 2

Details

Lead Sponsor:

Incyte Corporation